,16 Given that heterozygous LOF MBD4 variant carriers appear to be susceptible to uveal melanoma17, 18, 19 and our identification of uveal melanoma in three of eight individuals with MANS suggests annual ophthalmological surveillance may also be appropriate.20 This evidence concerns the gene MBD4 and tumor predisposition syndrome 2.